This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Girard, M. Articles by Fultz, P. N. Search for Related Content PubMed PubMed Citation Articles by Girard, M. Articles by Fultz, P. N.

 Previous Article  |  Next Article 

J. Virol., Nov 1996, 8229-8233, Vol 70, No. 11
Copyright © 1996, American Society for Microbiology

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B- derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain

M Girard, L Yue, F Barre-Sinoussi, E van der Ryst, B Meignier, E Muchmore and PN Fultz
Institut Pasteur, Paris, France.

Generation of an effective vaccine against human immunodeficiency virus type 1 (HIV-1) must overcome problems associated with extensive genetic diversity. Although we previously reported vaccine-induced protection of chimpanzees against infection with an HIV-1 strain different from the one used to make the immunogens, both the HIV-1 vaccine and challenge strains were classified within subtype B. To determine whether the HIV-1-specific immunity elicited might also prevent infection by a strain of HIV-1 from a different clade, the same chimpanzees were given booster inoculations with the rgp160-MN/LAI (recombinant hybrid gp160 molecule) and V3-MN immunogens and then were challenged by intravenous inoculation of a comparable dose of a subtype E HIV-1 from the Central African Republic. Both animals became infected with the subtype E virus, indicating that intraclade vaccine-mediated protection does not predict interclade protection, at least in the context of intravenous challenge and the HIV-1 strains used. This study has important implications for planned phase III efficacy trials of similar vaccine preparations in Thailand where HIV-1 subtype B and E strains cocirculate.

This article has been cited by other articles:

• Troyer, J. L., Pecon-Slattery, J., Roelke, M. E., Black, L., Packer, C., O'Brien, S. J. (2004). Patterns of Feline Immunodeficiency Virus Multiple Infection and Genome Divergence in a Free-Ranging Population of African Lions. J. Virol. 78: 3777-3791 [Abstract] [Full Text]  
• Heeney, J. L., Teeuwsen, V. J. P., van Gils, M., Bogers, W. M. J. M., Morghen, C. D. G., Radaelli, A., Barnett, S., Morein, B., Akerblom, L., Wang, Y., Lehner, T., Davis, D. (1998). beta -Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc. Natl. Acad. Sci. USA 95: 10803-10808 [Abstract] [Full Text]  
• Wei, Q., Fultz, P. N. (1998). Extensive Diversification of Human Immunodeficiency Virus Type 1 Subtype B Strains during Dual Infection of a Chimpanzee That Progressed to AIDS. J. Virol. 72: 3005-3017 [Abstract] [Full Text]